Grace Therapeutics, Inc. (GRCE) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Cash from Operations | -1.71M | -2.22M | -3.15M | -1.8M | -2.95M | -4.12M | -4.24M | -3.6M | -2.09M | -1.89M | -2.11M | -6.24M | -3.33M | -3.72M | -3.44M | -5.43M | -3.15M | -4.58M | -6.1M | -4.21M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 42.23% | 46.09% | 25.58% | 49.92% | -41.48% | -117.49% | -100.62% | 42.37% | 37.22% | 49.17% | 38.56% | -15% | -5.76% | 18.8% | 43.66% | -29% | -42.24% | 14.81% | -9.8% | 25.61% |
| Net Income | -1.18M | -2.31M | -938K | -3.36M | 636K | -4.16M | -3.43M | -2.62M | -3.17M | -2.39M | -3.27M | -4.02M | -29.09M | -3.89M | -4.93M | -4.52M | -3.9M | -3.78M | 981K | -3.86M |
| Depreciation & Amortization | 2K | 3K | 0 | 2K | 2K | 2K | 2K | 1K | 1K | 1K | 2K | 7K | 8K | 10K | -61K | 167K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | -24K | 314K | 0 | 302K | 130K | 160K | 202K | 238K | 229K | 326K | 280K | 78K | 322K | 443K | 582K | 464K | 616K | 454K | 114K | 189.22K |
| Deferred Taxes | -1.7M | 0 | 0 | 0 | -1.02M | -605K | -852K | -724K | -889K | -208K | -446K | -289K | -8.87M | -274K | -155K | -242K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 189.71K | -131.57K | -1.23M | 487K | -2.64M | 1.18M | -361K | -1.4M | 1.03M | -126K | 1.79M | 13K | 33.95M | 23K | -10K | -20K | -889K | -577K | -4.6M | 119.96K |
| Working Capital Changes | 1M | -88.78K | -983.5K | 770K | -66K | -695K | 202K | 901K | 704K | 506K | -464K | -2.03M | 353K | -35K | 1.13M | -1.27M | 1.03M | -683K | -2.6M | -659.18K |
| Change in Receivables | 1.48K | -1.27K | 250 | 106K | 175K | 114K | -19K | 326K | 237K | -122K | 0 | -35K | -34K | 91K | 75K | -434K | -310K | 579K | -380K | 115.02K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 15K | 0 | -15K | 6.55M | -6.55M | 110K | 0 | 4.99M | -5M | -96K | 13.26M | 11K | 557K | 2.84M | -8.57M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22K | 0 | 0 | 0 | -8K | 0 | -2K | -7K | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 110.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 15K | 0 | 0 | 1K | 0 | -73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -769 | 4.04M | -769 | -327K | 14.03M | 0 | 0 | 0 | 0 | 0 | 7.36M | 0 | 0 | 0 | 109K | 195K | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 51.88K | 5.51M | -769 | 0 | 15M | 0 | 0 | 0 | 0 | 0 | 7.34M | 0 | 0 | 0 | 109K | 195K | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -52.65K | -1.47M | 0 | -327K | -967K | 0 | 0 | 0 | 0 | 0 | 21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -1.7M | 1.81M | -3.14M | -2.13M | 11.08M | -4.1M | -4.24M | -3.61M | 4.46M | -8.45M | 5.36M | -6.24M | 1.63M | -8.69M | -3.45M | 8.04M | -2.67M | -3.92M | -4.05M | -12.33M |
| Free Cash Flow | -1.71M | -2.22M | -3.15M | -1.8M | -2.95M | -4.12M | -4.24M | -3.6M | -2.11M | -1.89M | -2.11M | -6.24M | -3.33M | -3.72M | -3.44M | -5.43M | -3.15M | -4.58M | -6.1M | -4.21M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 42.23% | 46.09% | 25.58% | 49.92% | -40% | -117.49% | -100.62% | 42.37% | 36.71% | 49.17% | 38.59% | -14.85% | -6.01% | 18.8% | 43.63% | -29.17% | -42.24% | 14.81% | -8.94% | 26.25% |
| FCF per Share | -0.10 | -0.13 | -0.20 | -0.11 | -0.21 | -0.36 | -0.37 | -0.33 | -0.21 | -0.16 | -0.28 | -0.84 | -0.45 | -0.50 | -0.46 | -0.74 | -0.46 | -0.62 | -1.12 | -0.97 |
| FCF Conversion (FCF/Net Income) | 1.45x | 0.70x | 2.41x | 0.54x | -3.26x | 0.69x | 1.24x | 1.00x | 0.49x | 0.60x | 0.48x | 1.17x | 0.08x | 0.71x | 0.51x | 0.93x | 0.64x | 0.95x | -4.91x | 0.88x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |